Nadir Mahmood returns to Nkarta a year after leaving; BeiGene picks longtime Merck exec for CFO post

For new Nkar­ta pres­i­dent Nadir Mah­mood, home is where the heart is.

The five-year vet­er­an of the NK cell ther­a­py biotech is re­turn­ing af­ter a …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.